Vertex to Participate in the Goldman Sachs 43rd Annual Healthcare Conference on June 15

Rhea-AI Summary

Vertex Pharmaceuticals (NASDAQ: VRTX) will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 1:20 p.m. PT. A live webcast will be available on Vertex's website in the 'Investors' section. Vertex is a biotechnology company focused on creating transformative medicines, especially for cystic fibrosis (CF), and has an extensive pipeline targeting diseases like sickle cell disease and type 1 diabetes. The company has received recognition for its workplace culture and innovation.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Wednesday, June 15, 2022 at 1:20 p.m. PT.

A live webcast of management's remarks will be available through Vertex's website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 12 consecutive years on Science magazine's Top Employers list and one of the 2021 Seramount (formerly Working Mother Media) 100 Best Companies. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20220608006068/en/

Vertex Pharmaceuticals Incorporated Investors:

Michael Partridge, 617-341-6108

Manisha Pai, 617-429-6891

Miroslava Minkova, 617-341-6135

Source: Vertex Pharmaceuticals Incorporated

FAQ

When is Vertex Pharmaceuticals participating in the Goldman Sachs Healthcare Conference?

Vertex Pharmaceuticals will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 1:20 p.m. PT.

Where can I watch Vertex Pharmaceuticals' conference webcast?

You can watch the live webcast of Vertex Pharmaceuticals' remarks on their website in the 'Investors' section under 'News and Events.'

What is Vertex Pharmaceuticals known for?

Vertex Pharmaceuticals is known for developing transformative medicines for serious diseases, especially cystic fibrosis, and has a robust pipeline for other genetic diseases.

What diseases does Vertex Pharmaceuticals focus on?

Vertex Pharmaceuticals focuses on cystic fibrosis and has ongoing research programs for sickle cell disease, type 1 diabetes, and other serious diseases.

What recognition has Vertex Pharmaceuticals received?

Vertex Pharmaceuticals has been recognized as one of the industry's top places to work and has appeared on Science magazine's Top Employers list for 12 consecutive years.